Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an options trading signal again: unusual options activity screeners and strategies. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Prophase Labs Inc (PRPH)

Prophase Labs Inc (PRPH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 164,245
  • Shares Outstanding, K 16,278
  • Annual Sales, $ 79,040 K
  • Annual Income, $ 6,270 K
  • 60-Month Beta -0.32
  • Price/Sales 2.08
  • Price/Cash Flow 25.73
  • Price/Book 2.38
Trade PRPH with:

Options Overview Details

View History
  • Implied Volatility 66.80% ( -21.24%)
  • Historical Volatility 62.79%
  • IV Percentile 49%
  • IV Rank 49.15%
  • IV High 118.66% on 07/22/22
  • IV Low 16.68% on 02/28/22
  • Put/Call Vol Ratio 1.00
  • Today's Volume 14
  • Volume Avg (30-Day) 22
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 760
  • Open Int (30-Day) 786

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate 0.02
  • Number of Estimates 1
  • High Estimate 0.02
  • Low Estimate 0.02
  • Prior Year 0.44
  • Growth Rate Est. (year over year) -95.45%

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.89 +3.44%
on 11/30/22
12.69 -19.39%
on 11/08/22
-2.04 (-16.63%)
since 11/07/22
3-Month
8.87 +15.33%
on 10/19/22
12.69 -19.39%
on 11/08/22
-1.02 (-9.07%)
since 09/07/22
52-Week
6.20 +65.00%
on 03/02/22
15.25 -32.92%
on 07/11/22
+3.59 (+54.07%)
since 12/07/21

Most Recent Stories

More News
ProPhase Labs, Inc. (PRPH) Q3 Earnings Miss Estimates

ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of -60% and 28.38%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

PRPH : 10.23 (+1.39%)
IMPL : 2.87 (+1.06%)
Are Investors Undervaluing Assertio (ASRT) Right Now?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest...

ASRT : 3.44 (+2.38%)
PRPH : 10.23 (+1.39%)
The Zacks Analyst Blog highlights Consolidated Water, Ashford Hospitality Trust, BankFinancial, LogicBio Therapeutics and ProPhase Labs

Consolidated Water, Ashford Hospitality Trust, BankFinancial, LogicBio Therapeutics and ProPhase Labs are part of the Zacks top Analyst Blog .

AHT : 5.87 (-3.61%)
CWCO : 14.76 (+1.65%)
BFIN : 9.61 (-0.52%)
PRPH : 10.23 (+1.39%)
LOGC : 2.07 (+0.49%)
5 Big Winners as Dollar Strengthens on Fed Rate Hike

A stronger dollar is a boon for Consolidated Water (CWCO), Ashford Hospitality Trust (AHT), BankFinancial (BFIN), LogicBio Therapeutics (LOGC) and ProPhase Labs (PRPH) that have high domestic exposure...

AHT : 5.87 (-3.61%)
CWCO : 14.76 (+1.65%)
BFIN : 9.61 (-0.52%)
PRPH : 10.23 (+1.39%)
LOGC : 2.07 (+0.49%)
Are Medical Stocks Lagging ProPhase Labs (PRPH) This Year?

Here is how ProPhase Labs, Inc. (PRPH) and Concert Pharmaceuticals (CNCE) have performed compared to their sector so far this year.

PRPH : 10.23 (+1.39%)
CNCE : 4.34 (-3.98%)
5 Cheap Healthcare Stocks in 2022

Energy, banks and agriculture have plenty of value stocks this year but what about healthcare?

ABC : 170.29 (+0.57%)
PDCO : 28.55 (-0.87%)
AMN : 118.83 (+1.04%)
PRPH : 10.23 (+1.39%)
ASRT : 3.44 (+2.38%)
Here's Why ProPhase Labs, Inc. (PRPH) is a Great Momentum Stock to Buy

Does ProPhase Labs, Inc. (PRPH) have what it takes to be a top stock pick for momentum investors? Let's find out.

PRPH : 10.23 (+1.39%)
Is DBV Technologies (DBVT) Stock Outpacing Its Medical Peers This Year?

Here is how DBV Technologies S.A. (DBVT) and ProPhase Labs, Inc. (PRPH) have performed compared to their sector so far this year.

DBVT : 1.2800 (-2.29%)
PRPH : 10.23 (+1.39%)
ProPhase Labs, Inc. (PRPH) Tops Q2 Earnings and Revenue Estimates

ProPhase Labs, Inc. (PRPH) delivered earnings and revenue surprises of 233.33% and 28.16%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

PRPH : 10.23 (+1.39%)
AYLA : 0.5863 (-2.41%)
Lyra Therapeutics, Inc. (LYRA) Reports Q2 Loss, Lags Revenue Estimates

Lyra Therapeutics, Inc. (LYRA) delivered earnings and revenue surprises of -26.47% and 92.42%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

LYRA : 3.20 (-3.32%)
PRPH : 10.23 (+1.39%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

ProPhase Labs, Inc., formerly known as The Quigley Corporation, is a manufacturer, marketer and distributor of a diversified range of homeopathic and health products that are offered to the general public. The Company's mission is to develop and market natural health care pharmaceuticals and nutriceuticals...

See More

Key Turning Points

3rd Resistance Point 10.59
2nd Resistance Point 10.44
1st Resistance Point 10.34
Last Price 10.23
1st Support Level 10.08
2nd Support Level 9.93
3rd Support Level 9.82

See More

52-Week High 15.25
Fibonacci 61.8% 11.79
Fibonacci 50% 10.73
Last Price 10.23
Fibonacci 38.2% 9.66
52-Week Low 6.20

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar